BioSpace News Archive

Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical pathology A.I. platform, to advance clinical pathology by improving whole slide imaging of non-histology samples.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the promotion of Nicole Lambert to chief operating officer.

Veracyte, Inc. (Nasdaq: VCYT) announced today the publication of clinical utility data confirming the ability of the Envisia Genomic Classifier to improve diagnostic and treatment decision-making for patients with idiopathic pulmonary fibrosis (IPF).

Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced that it has raised over $110 million in a combined Series E and debt financing.

Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced three poster presentations related to imetelstat, the Company’s first in class telomerase inhibitor, at the 63rd American Society of Hematology (ASH) Annual Meeting.

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for ruxolitinib cream 1.5% (Opzelura™) a topical JAK inhibitor, as a potential treatment for adolescents and adults (age ≥12 years) with vitiligo.

Legend Biotech Corporation announced that it intends to offer and sell $300.0 million of American Depositary Shares, each representing two ordinary shares, in an underwritten public offering.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant (B.1.1.529).

These highly prestigious awards are in recognition of Professor Robinson’s contributions to the field of mass spectrometry and for establishing it as a method to analyse proteins in their native state.

City of Hope, a world-renowned cancer research and treatment organization, announced study results of a Phase 2 clinical trial showing monotherapy with sotorasib resulted in anti-tumor activity and a favorable benefit-risk profile among heavily pretreated patients with advanced colorectal cancer.